Literature DB >> 4163891

Hypofibrinogenaemia without increased fibrinolysis in leukaemia.

J Hirsh, J G Buchanan, G C De Gruchy, A G Baikie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4163891     DOI： 10.1016/s0140-6736(67)91178-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Hypofibrinogenaemia as a cause of bleeding in chronic myeloid leukaemia.

Authors:  J A Whittaker; M Khurshid
Journal:  Br Med J       Date:  1975-03-01

2.  Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.

Authors:  L Jorgensen; J Hirsh; M F Glynn; M R Buchanan; J F Mustard
Journal:  Am J Pathol       Date:  1971-01       Impact factor: 4.307

3.  Fibrinolysis in leukaemia.

Authors:  D Ogston; G M McAndrew; C M Ogston
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

4.  Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia.

Authors:  G Sunder-Plassmann; W Speiser; C Korninger; M Stain; P Bettelheim; I Pabinger-Fasching; K Lechner
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

5.  Placental barrier to coagulation factors: its relevance to the coagulation defect at birth and to haemorrhage in the newborn.

Authors:  J F Cade; J Hirsh; M Martin
Journal:  Br Med J       Date:  1969-05-03

6.  Coagulant activity of leukocytes. Tissue factor activity.

Authors:  J Niemetz
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.